Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Kraler

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Investigation|April 7, 2025
Machine learning in cardiovascular risk assessment: Towards a precision medicine approachYifan Wang, Evmorfia Aivalioti, Kimon Stamatelopoulos, et al.
European Journal of Clinical Investigation|December 4, 2025
IL-6 in the spotlight: From cardiovascular pathophysiology to therapyAlberto Preda, Amedeo Tirandi, Giulio Leo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 11, 2024
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS studyFrancesco Bruno, Florian A Wenzl, Ovidio De Filippo, et al.
International Journal of Cardiology|March 23, 2023
History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbiditiesAndrea Denegri, Giulia Magnani, Simon Kraler, et al.
European Journal of Clinical Investigation|October 1, 2024
Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromesJan Gerrit van der Stouwe, Konstantin Godly, Simon Kraler, et al.
JACC. Basic to Translational Science|March 25, 2025
Endothelial JCAD Worsens Acute Ischemic Stroke Outcomes by Enhancing Inflammation in Response to Ischemia/ReperfusionStefano Ministrini, Yustina M Puspitasari, Georgia Beer, et al.
Lancet (London, England)|September 1, 2022
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validationFlorian A Wenzl, Simon Kraler, Gareth Ambler, et al.
Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
Cardiovascular Research|March 22, 2021
Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cyclingSenka Ljubojević-Holzer, Simon Kraler, Nataša Djalinac, et al.
European Heart Journal|August 26, 2023
Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromesFlorian A Wenzl, Francesco Bruno, Simon Kraler, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Investigation|April 7, 2025
Machine learning in cardiovascular risk assessment: Towards a precision medicine approachYifan Wang, Evmorfia Aivalioti, Kimon Stamatelopoulos, et al.
European Journal of Clinical Investigation|December 4, 2025
IL-6 in the spotlight: From cardiovascular pathophysiology to therapyAlberto Preda, Amedeo Tirandi, Giulio Leo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 11, 2024
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS studyFrancesco Bruno, Florian A Wenzl, Ovidio De Filippo, et al.
International Journal of Cardiology|March 23, 2023
History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbiditiesAndrea Denegri, Giulia Magnani, Simon Kraler, et al.
European Journal of Clinical Investigation|October 1, 2024
Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromesJan Gerrit van der Stouwe, Konstantin Godly, Simon Kraler, et al.
JACC. Basic to Translational Science|March 25, 2025
Endothelial JCAD Worsens Acute Ischemic Stroke Outcomes by Enhancing Inflammation in Response to Ischemia/ReperfusionStefano Ministrini, Yustina M Puspitasari, Georgia Beer, et al.
Lancet (London, England)|September 1, 2022
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validationFlorian A Wenzl, Simon Kraler, Gareth Ambler, et al.
Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
Cardiovascular Research|March 22, 2021
Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cyclingSenka Ljubojević-Holzer, Simon Kraler, Nataša Djalinac, et al.
European Heart Journal|August 26, 2023
Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromesFlorian A Wenzl, Francesco Bruno, Simon Kraler, et al.
Pageof 6